FOR BREAKING NEWS VISIT WWW.QNS.COM  NOVEMBER 5, 2020 • HEALTH • THE QUEENS COURIER 33 
  health 
 How technology is helping people better  
 manage diabetes during COVID-19 
 Th  e impact of COVID-19 has changed  
 many aspects of our everyday lives, particularly  
 for those living with a chronic  
 condition like diabetes. Even under normal  
 circumstances,  managing  diabetes  
 can be diffi  cult, but with the added challenges  
 of the pandemic, access to medical  
 care, medications, and other diabetes  
 products has become increasingly diffi  - 
 cult for many. 
 Living with diabetes is expensive. Th e  
 average yearly cost to manage the condition  
 is almost $10,000, and data show that  
 two in fi ve Americans living with diabetes  
 experience fi nancial hardship from medical  
 bills - even when properly insured.  
 Since the pandemic began, as many as  
 18 percent of Americans with diabetes  
 have faced unemployment, making the  
 ability to aff ord medication and medical  
 care an even greater challenge. As a result,  
 many people living with diabetes were not  
 adhering to their diabetes management  
 regimens,  which  may  jeopardize  their  
 overall health, especially considering this  
 community is at risk of developing more  
 serious complications from the virus. 
 In fact, a study from earlier this summer  
 found that one in four people with  
 diabetes have started skipping medication  
 doses and testing their glucose less oft en  
 to extend their supplies. 
 Th  e  pandemic  is  not  only  impacting  
 fi nances, it is also changing the way  
 healthcare is delivered. Th  ere has been  
 a greater acceptance of telehealth and  
 remote monitoring for chronic conditions  
 like diabetes from both patients and  
 the  healthcare industry - underscoring  
 the important role that diabetes technology  
 can play. 
 One example of a technology that is  
 helping physicians monitor their patients  
 remotely is integrated continuous glucose  
 monitors (iCGMs) like Abbott’s FreeStyle  
 Libre 2 system, which features a small  
 sensor worn on the back of the upper  
 arm for up to 14 days and accurately measures  
 glucose every minute, eliminating  
 the need for fi ngersticks. 
 With a one-second scan using a handheld  
 reader, adults and children ages four  
 and up can see their real-time glucose  
 reading, an eight-hour history of glucose  
 data and a trend arrow showing where  
 their levels are heading. Th ese actionable  
 insights allow people with diabetes and  
 their physicians to make more informed  
 decisions about treatments, exercise and  
 nutrition,  even  when  in-person  visits  
 aren’t possible. 
 “My continuous glucose monitor has  
 greatly improved my quality of life. I  
 no  longer  need  to  do  multiple,  painful  
 fi ngersticks a day and can see which  
 direction my glucose levels are trending, 
  which makes managing my diabetes  
 so much easier,” said Kendall Kidder- 
 Goshorn, who has been living with type 1  
 diabetes for 26 years. “When I’m using the  
 FreeStyle Libre 2, I spend less time worrying  
 about my glucose levels, so CGM  
 technology is directly responsible for me  
 being the healthiest I’ve been in years. I  
 think every person living with diabetes  
 should have access to revolutionary technologies  
 like CGMs, so they can be their  
 healthiest self, too.” 
 As CGMs have shown evidence to be  
 eff ective at helping people with diabetes  
 better manage their condition and  
 improve health outcomes, they are being  
 more widely embraced. For instance, the  
 Centers for Medicare & Medicaid Services  
 (CMS) now provides reimbursement for  
 the FreeStyle Libre 2 system and recently  
 gave healthcare professionals more fl exibility  
 to prescribe CGMs during the pandemic. 
  While this marks signifi cant progress, 
  many people with diabetes still can’t  
 access CGMs due to insurance restrictions  
 or high-deductible costs and copays. 
 “From the start, Abbott set out to make  
 our  FreeStyle  Libre  portfolio  available  
 to as many people living with diabetes  
 as possible. Th  at’s why we priced it 70%  
 lower than other CGMs, without sacrifi  
 cing performance and accuracy,” said  
 Mahmood  Kazemi,  M.D.,  chief  medical  
 offi  cer, Diabetes Care, Abbott. “We’re  
 working to ensure all people living with  
 diabetes have access to the life-changing  
 benefi ts of our technology, all at a fraction  
 of the cost of other available CGMs.” 
 Life  with  diabetes  can  be  stressful  
 enough, but with access to breakthrough  
 technology like CGMs, daily care can be  
 simpler to manage, even during a pandemic. 
  Talk to your doctor for information  
 about how you could manage your  
 diabetes more eff ectively and aff ordably  
 or visit www.freestylelibre.us/ or www. 
 freestylelibre.us/myfreestyle.html to learn  
 more. 
 — Courtesy of BPT 
 
				
/WWW.QNS.COM
		/myfreestyle.html
		/myfreestyle.html
		/
		/
		/myfreestyle.html